Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients

NAUnknownINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

March 1, 2024

Study Completion Date

June 1, 2024

Conditions
Pancreatic Cancer Non-resectable
Interventions
RADIATION

stereotactic ablative radiotherapy

SABR will be delivered in an image-guided hypofractionated scheme of 5 fractions of 8 Gy (total 40 Gy), prescribed to 95% of the planning target volume (PTV). Treatment is delivered on alternate days within a maximum overall treatment duration of 14 days.

Trial Locations (2)

1117 HV

RECRUITING

VUMedicalCenter, Amsterdam

3584CX

RECRUITING

UMCU, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Dutch Cancer Society

OTHER

collaborator

Viewray Inc.

INDUSTRY

lead

Amsterdam UMC, location VUmc

OTHER